The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (5) , 1629-1638
- https://doi.org/10.1124/mol.104.010223
Abstract
The human organic anion transporter 2 (hOAT2, SLC22A7) mediates the sodium-independent uptake of numerous drugs, including cephalosporins, salicylates, dicarboxylates, and prostaglandins, and is mainly expressed in hepatocytes. Because the regulation of hOAT2 expression is poorly understood, we characterized cis-acting elements in the 5′-flanking region that regulate hOAT2 transcription. A consensus binding motif for the hepatocyte nuclear factor-4α (HNF-4α), arranged as a direct repeat (DR)-1, is located at nucleotides –329/-317 relative to the transcription initiation site. This element specifically binds HNF-4α in electrophoretic mobility shift assays. A luciferase-linked hOAT2 promoter fragment containing the HNF-4α binding site was transactivated upon cotransfection of an HNF-4α expression vector in Huh7 cells, whereas site-directed mutagenesis of the DR-1 element abolished activation by HNF-4α. Short interfering RNAs inhibiting endogenous HNF-4α expression markedly reduced endogenous expression of hOAT2 in Huh7 cells. Because HNF-4α is a known target for bile acid-mediated repression of gene transcription, we studied whether chenodeoxycholic acid (CDCA) suppresses hOAT2 gene expression by inhibiting HNF-4α-mediated transactivation. Treatment of Huh7 cells with CDCA or the synthetic farnesoid X receptor (FXR) agonist GW4064 decreased mRNA and protein levels and also nuclear binding activity of HNF-4α. The FXR-inducible transcriptional repressor small heterodimer partner inhibited transactivation of hOAT2 promoter constructs and of endogenous hOAT2 expression by HNF-4α. We conclude that the hOAT2 gene is critically dependent on HNF-4α and that bile acids repress the hOAT2 gene by inhibiting HNF-4α. Hepatic uptake of hOAT2 substrates may thus be decreased in disease conditions associated with elevated intracellular levels of bile acids.Keywords
This publication has 46 references indexed in Scilit:
- Coordinate transcriptional regulation of bile acid homeostasis and drug metabolismArchives of Biochemistry and Biophysics, 2005
- Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasisHepatology, 2004
- Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed CycleJournal of Biological Chemistry, 2003
- Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4α (HNF4α)Gene, 2003
- Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expressionGastroenterology, 2003
- Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementJournal of Clinical Investigation, 2002
- The Negative Effects of Bile Acids and Tumor Necrosis Factor-α on the Transcription of Cholesterol 7α-Hydroxylase Gene (CYP7A1) Converge to Hepatic Nuclear Factor-4Journal of Biological Chemistry, 2001
- Effects of Ursodeoxycholic and Cholic Acid Feeding on Hepatocellular Transporter Expression in Mouse LiverGastroenterology, 2001
- VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanismAmerican Journal of Physiology-Cell Physiology, 2000
- Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligationJournal of Hepatology, 1997